MenuEN
News and Events

News



Montreal, February 9th, 2010 – Concerned with the health and well being of Canadians, the J. Armand Bombardier Foundation has donated $200 000 to the PROCURE Quebec Prostate Cancer Biobank, a tool to accelerate the pace of research on prostate cancer.
PROCURE and the three Montréal Sport clubs present the Walk of Courage: Because each step is important

PROCURE, Québec prostate cancer foundation, in association with the Montréal Canadians, the Montréal Alouettes and the Montréal Impact, is proud to present the 2009 PROCURE Walk of Courage. They invite you to register on the following Web site www.marcheprocure.com to have a chance at winning prizes.
Pat Burns Passes the Torch to Henri Richard and Mayor Gérald Tremblay for the 2008 PROCURE Walk of Courage

Veuillez noter que vos conjointes sont bienvenues
The campaign heats up on September 14th, 2006
Taxotere® was approved by Health Canada for men with prostate cancer.
Eligard® 45mg (a luteinizing hormone-releasing hormone LHRH agonist) is now available for the treatment of advanced prostate cancer (stage D2) in Canada.
The Régie d’assurance maladie du Québec (RAMQ) agreed to reimburse the costs of Zometa (zoledronic acid) through the “patient d’exception” process.

Page: 1/2  [next]



1-866-899-CURE


The information on this Web site is not medical advice and should not be used as a substitute for medical advice, diagnosis or treatment. Nor should it be used in place of a visit, call, consultation or advice of your physician or other health care provider. PROCURE does not recommend the self-management of health problems, nor do we promote or recommend any particular form of medical treatment.

This website has been made possible with the generous support of Manulife Financial.

© 2007 PROCURE     Terms of Use